Predicting the Impact of Adverse Events and Treatment Duration on Medical Resource Utilisation Related Costs in Hepatitis C Genotype 1 Treatment-Naïve Patients Receiving Antiviral Therapy
Abstract
Authors
H. Akpo K. Cerri U. Sbarigia J. Kleintjens